SCHEDULE 13G/A

Tarsus Pharmaceuticals Inc

Common Stock, par value $0.0001 per share · CUSIP: 87650L103

Event date: 2025-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• TANG CAPITAL MANAGEMENT, LLC

  Shares: 1,188,624.00 · Class: 2.80%

• KEVIN TANG

  Shares: 1,188,624.00 · Class: 2.80%

• TANG CAPITAL PARTNERS, LP

  Shares: 345,686.00 · Class: 0.81%

• TANG CAPITAL PARTNERS INTERNATIONAL, LP

  Shares: 784,938.00 · Class: 1.85%

• TANG CAPITAL PARTNERS III, INC

  Shares: 43,500.00 · Class: 0.10%

• TANG CAPITAL PARTNERS IV, INC

  Shares: 14,500.00 · Class: 0.04%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.